Vortex Biosciences, Inc. is developing a novel liquid biopsy technology that could revolutionize cancer diagnosis, monitoring and treatment.
The technology Vortex uses is as complex as the cancers the company
is fighting. Could we present the scientific research so it’s easier for both academics and investors to understand at a glance?
Tapping into the concepts of "cognitive fluency", we distilled
the information into small nuggets of information. Accompanying icons let users absorb complex ideas while scrolling.
